ZipBio, a biotechnology company pioneering AI-driven protein therapeutics, announced an exclusive license agreement with MeiraGTx Holdings plc , a vertically integrated, clinical-stage genetic ...

Galux, a South Korean biotech doing research on AI-driven protein therapeutics discovery, entered into a research agreement with Boehringer Ingelheim to jointly explore the application of artificial ...

Abstract: Computational protein design is experiencing a transformation driven by AI/ML. However, the range of potential protein sequences and structures is astronomically vast, even for moderately ...

Multichain biotherapeutics continue to be a promising therapeutic modality. “These therapeutic recombinant proteins are typically assembled from at least three distinct polypeptide chains,” says ...

The ability to express heterologous proteins in specific plant tissues and subcellular compartments is critical for advancing plant-based biotechnologies and biopharming research. Here, we present the ...

Kevin K. Yang, Sarah Alamdari, Alex J. Lee, Kaeli Kaymak-Loveless, Samir Char, Garyk Brixi, Carles Domingo-Enrich, Chentong Wang, Suyue Lyu, Nicolo Fusi, Philip Rosenfield, Neil Tenenholtz, Ava P.

Jue Wang (left) is a research scientist and one of the scientific leads of the protein design team at Google DeepMind (London, UK). Before joining DeepMind, Jue was a postdoc with David Baker ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported new results from Study 9001-103. Also known as ...

All aspects of upstream bioprocessing are under pressure to increase expression titers and improve product quality (PQ). To date, major advancements in the glutamine synthetase (GS) system for Chinese ...

Jingjing Gong, Yu Pei, Siyu Long, Yuxuan Song, Zhe Zhang, Wenhao Huang, Ziyao Cao, Shuyi Zhang, Hao Zhou, Wei-Ying Ma ...